Rates have not improved since a prepandemic guideline update.

Takeaway

• Most European patients who need lipid-lowering therapy do not achieve risk-based cholesterol goal levels.

• Physicians may misclassify these patients’ cardiovascular risks and avoid combination medication therapies.